Home/Filings/4/A/0001209191-15-050904
4/A//SEC Filing

Arcadia Biosciences, Inc. 4/A

Accession 0001209191-15-050904

$RKDACIK 0001469443operating

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 1:19 PM ET

Size

16.1 KB

Accession

0001209191-15-050904

Insider Transaction Report

Form 4/AAmended
Period: 2015-05-20
Transactions
  • Purchase

    Common Stock

    2015-05-20$8.00/sh+375,000$3,000,0009,080,808 total(indirect: By Mandala Capital AG Limited)
  • Conversion

    Common Stock

    2015-05-20+8,705,8088,705,808 total
  • Conversion

    Series D Convertible Preferred Stock

    2015-05-208,918,7500 total
    Common Stock (8,705,808 underlying)
Transactions
  • Conversion

    Common Stock

    2015-05-20+8,705,8088,705,808 total
  • Purchase

    Common Stock

    2015-05-20$8.00/sh+375,000$3,000,0009,080,808 total(indirect: By Mandala Capital AG Limited)
  • Conversion

    Series D Convertible Preferred Stock

    2015-05-208,918,7500 total
    Common Stock (8,705,808 underlying)
Transactions
  • Conversion

    Series D Convertible Preferred Stock

    2015-05-208,918,7500 total
    Common Stock (8,705,808 underlying)
  • Conversion

    Common Stock

    2015-05-20+8,705,8088,705,808 total
  • Purchase

    Common Stock

    2015-05-20$8.00/sh+375,000$3,000,0009,080,808 total(indirect: By Mandala Capital AG Limited)
Transactions
  • Purchase

    Common Stock

    2015-05-20$8.00/sh+375,000$3,000,0009,080,808 total(indirect: By Mandala Capital AG Limited)
  • Conversion

    Series D Convertible Preferred Stock

    2015-05-208,918,7500 total
    Common Stock (8,705,808 underlying)
  • Conversion

    Common Stock

    2015-05-20+8,705,8088,705,808 total
Gujadhur Tej
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-05-20+8,705,8088,705,808 total
  • Purchase

    Common Stock

    2015-05-20$8.00/sh+375,000$3,000,0009,080,808 total(indirect: By Mandala Capital AG Limited)
  • Conversion

    Series D Convertible Preferred Stock

    2015-05-208,918,7500 total
    Common Stock (8,705,808 underlying)
Footnotes (3)
  • [F1]The Series D Preferred Stock converted into Arcadia Biosciences, Inc. common stock on a conversion ratio of one share of common stock for approximately every 1.0245 shares of preferred stock upon the closing of the issuer's initial public offering of common stock, and had no expiration date. The conversion ratio reflected an adjustment due to the issuer's 1-for-4 reverse stock split effected on May 8, 2015.
  • [F2]The Series D preferred stock which converted into Arcadia Biosciences, Inc. common stock is held by Mandala Agribusiness Co-Investments I Limited.
  • [F3]Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur are members of the board of Mandala Agribusiness Fund, which exercises shared voting and investment power over the shares owned by Mandala Agribusiness Co-Investments I Limited and also the shares owned by Mandala Capital AG Limited. Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur disclaim beneficial ownership of all securities listed herein, except to the extent of their respective pecuniary interests therein.

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001469443

Filing Metadata

Form type
4/A
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 1:19 PM ET
Size
16.1 KB